Compare Macerich Company (The) Common Stock (MAC) vs NeoGenomics Inc. Common Stock (NEO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Macerich Company (The) Common Stock vs NeoGenomics Inc. Common Stock — how do they compare? Macerich Company (The) Common Stock trades at $22.18 (market cap $6.39B), while NeoGenomics Inc. Common Stock trades at $16.85 (market cap $2.14B). The key difference: Macerich Company (The) Common Stock is far larger — about 3× NeoGenomics Inc. Common Stock's market cap, and Macerich Company (The) Common Stock pays a 3.02% dividend while NeoGenomics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Macerich Company (The) Common Stock for 0 Days and NeoGenomics Inc. Common Stock for 0 Days on average.
| MAC | NEO | |
|---|---|---|
Market Cap | $6.39B | $2.14B |
Volume | 2,684,151 | 2,228,400 |
Sector | Real Estate | Health |
52-Week High | $26.51 | $19.91 |
52-Week Low | $16.20 | $7.19 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $11.07B | $2.44B |
Dividend Yield | 3.02% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Macerich Company (The) Common Stock
The Macerich Company is a real estate investment trust that owns, operates, and redevelops shopping centers concentrated in California, the Pacific Northwest, and other major US markets.
Read more on MAC →About NeoGenomics Inc. Common Stock
NeoGenomics, Inc. is a US cancer diagnostics company that provides genomic and pathology testing services, offering an oncology-focused testing menu used by oncologists, pathologists, and hospital systems across the cancer care continuum.
Read more on NEO →
